The 14 key points of the Pfizer and BioNTech vaccine that the FDA will review
Experts from the drug regulatory agency will examine the conclusions of clinical studies of the formula, which cover 38 thousand patients Experts from the United States drug agency (FDA) considered in a report published on Tuesday that the vaccine against covid-19 from the laboratories Pfizer and BioNTech does not present safety risks, so everything seems … Read more